Patent · US Active

PAR3 mimetic peptides and uses thereof

US11306130B2 · kind B2 · utility

0Cited by

3References

8Claims

0Family size

Assignees

Arizona Board of Regents on Behalf of the University of Arizona · US
The Board of Regents of the University of Texas System · US

Inventors

Josef Vagner · Tucson, US
Scott A. Boitano · Tucson, US
Theodore J. Price · Austin, US
Gregory O. Dussor · Austin, US

Key dates

Filing date	Mar 31, 2017
Grant date	Apr 19, 2022
Priority date	—
Expiry date	Jan 25, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 3 (PAR3) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR3 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.